Intraocular Lens (IOL) - Medical Devices Pipeline Assessment, 2020

1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Intraocular Lens (IOL) Overview

3 Products under Development
3.1 Intraocular Lens (IOL) - Pipeline Products by Stage of Development
3.2 Intraocular Lens (IOL) - Pipeline Products by Segment
3.3 Intraocular Lens (IOL) - Pipeline Products by Territory
3.4 Intraocular Lens (IOL) - Pipeline Products by Regulatory Path
3.5 Intraocular Lens (IOL) - Pipeline Products by Estimated Approval Date
3.6 Intraocular Lens (IOL) - Ongoing Clinical Trials

4 Intraocular Lens (IOL) - Pipeline Products under Development by Companies
4.1 Intraocular Lens (IOL) Companies - Pipeline Products by Stage of Development
4.2 Intraocular Lens (IOL) - Pipeline Products by Stage of Development

5 Intraocular Lens (IOL) Companies and Product Overview
5.1 Abbott Medical Optics Inc Company Overview
5.1.1 Abbott Medical Optics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 AcuFocus Inc Company Overview
5.2.1 AcuFocus Inc Pipeline Products & Ongoing Clinical Trials Overview
5.3 Adaptilens LLC Company Overview
5.3.1 Adaptilens LLC Pipeline Products & Ongoing Clinical Trials Overview
5.4 Adoptics AG (Inactive) Company Overview
5.4.1 Adoptics AG (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.5 AkkoLens International BV Company Overview
5.5.1 AkkoLens International BV Pipeline Products & Ongoing Clinical Trials Overview
5.6 Alcon Inc Company Overview
5.6.1 Alcon Inc Pipeline Products & Ongoing Clinical Trials Overview
5.7 Anew Optics, Inc. Company Overview
5.7.1 Anew Optics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.8 Atia Vision Inc Company Overview
5.8.1 Atia Vision Inc Pipeline Products & Ongoing Clinical Trials Overview
5.9 Bausch & Lomb Inc Company Overview
5.9.1 Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview
5.10 Care Group Company Overview
5.10.1 Care Group Pipeline Products & Ongoing Clinical Trials Overview
5.11 Clarvista Medical Inc Company Overview
5.11.1 Clarvista Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.12 ClearSight LLC Company Overview
5.12.1 ClearSight LLC Pipeline Products & Ongoing Clinical Trials Overview
5.13 Elenza, Inc. Company Overview
5.13.1 Elenza, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.14 Emmetrope Incorporated Company Overview
5.14.1 Emmetrope Incorporated Pipeline Products & Ongoing Clinical Trials Overview
5.15 EyeKon Medical Inc Company Overview
5.15.1 EyeKon Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.16 Hoya Surgical Optics Inc Company Overview
5.16.1 Hoya Surgical Optics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.17 InnFocus Inc Company Overview
5.17.1 InnFocus Inc Pipeline Products & Ongoing Clinical Trials Overview
5.18 Innovia LLC Company Overview
5.18.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview
5.19 Johnson & Johnson Vision Care Inc Company Overview
5.19.1 Johnson & Johnson Vision Care Inc Pipeline Products & Ongoing Clinical Trials Overview
5.20 LayerBio Inc Company Overview
5.20.1 LayerBio Inc Pipeline Products & Ongoing Clinical Trials Overview
5.21 LensGen, Inc. Company Overview
5.21.1 LensGen, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.22 Lenstec Inc Company Overview
5.22.1 Lenstec Inc Pipeline Products & Ongoing Clinical Trials Overview
5.23 London Eye Hospital Company Overview
5.23.1 London Eye Hospital Pipeline Products & Ongoing Clinical Trials Overview
5.24 Medicontur Medical Engineering Ltd Company Overview
5.24.1 Medicontur Medical Engineering Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.25 Meir Medical Center Company Overview
5.25.1 Meir Medical Center Pipeline Products & Ongoing Clinical Trials Overview
5.26 Morcher Gmbh Company Overview
5.26.1 Morcher Gmbh Pipeline Products & Ongoing Clinical Trials Overview
5.27 Nayam Innovations Pvt Ltd Company Overview
5.27.1 Nayam Innovations Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.28 Nidek Co Ltd Company Overview
5.28.1 Nidek Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.29 Northwestern University Company Overview
5.29.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
5.30 NuLens Ltd. (Inactive) Company Overview
5.30.1 NuLens Ltd. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.31 Ocumetics Technology Corp Company Overview
5.31.1 Ocumetics Technology Corp Pipeline Products & Ongoing Clinical Trials Overview
5.32 Omega Ophthalmics LLC Company Overview
5.32.1 Omega Ophthalmics LLC Pipeline Products & Ongoing Clinical Trials Overview
5.33 PhysIOL SA Company Overview
5.33.1 PhysIOL SA Pipeline Products & Ongoing Clinical Trials Overview
5.34 Presbeasy Company Overview
5.34.1 Presbeasy Pipeline Products & Ongoing Clinical Trials Overview
5.35 Rayner Intraocular Lenses Ltd Company Overview
5.35.1 Rayner Intraocular Lenses Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.36 Sav-Iol SA Company Overview
5.36.1 Sav-Iol SA Pipeline Products & Ongoing Clinical Trials Overview
5.37 STAAR Surgical Company Company Overview
5.37.1 STAAR Surgical Company Pipeline Products & Ongoing Clinical Trials Overview
5.38 Strathspey Crown LLC Company Overview
5.38.1 Strathspey Crown LLC Pipeline Products & Ongoing Clinical Trials Overview
5.39 University of East Anglia Company Overview
5.39.1 University of East Anglia Pipeline Products & Ongoing Clinical Trials Overview
5.40 University of Rochester Company Overview
5.40.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview
5.41 University of Tampere Company Overview
5.41.1 University of Tampere Pipeline Products & Ongoing Clinical Trials Overview
5.42 Visidome Ltd Company Overview
5.42.1 Visidome Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.43 Visioneering Technologies Inc Company Overview
5.43.1 Visioneering Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.44 VisusNano Labs Company Overview
5.44.1 VisusNano Labs Pipeline Products & Ongoing Clinical Trials Overview
5.45 VSY Biotechnology BV Company Overview
5.45.1 VSY Biotechnology BV Pipeline Products & Ongoing Clinical Trials Overview
5.46 Washington University in St Louis Company Overview
5.46.1 Washington University in St Louis Pipeline Products & Ongoing Clinical Trials Overview
5.47 Xend Company Overview
5.47.1 Xend Pipeline Products & Ongoing Clinical Trials Overview
5.48 Z Lens LLC Company Overview
5.48.1 Z Lens LLC Pipeline Products & Ongoing Clinical Trials Overview

6 Intraocular Lens (IOL)- Recent Developments
6.1 Oct 23, 2020: Mentice receives order of total SEK 7.1 million from ABBOTT
6.2 Sep 07, 2020: Pomerantz law firm announces the filing of a class action against Staar Surgical Company and certain officers - STAA
6.3 Jul 12, 2020: Bausch + Lomb expanding Virginia operation, creating 79 new jobs
6.4 Apr 16, 2020: Abbott reports first-quarter 2020 results
6.5 Apr 13, 2020: STAAR Surgical provides covid-19 business update
6.6 Apr 07, 2020: Alcon provides update on covid-19
6.7 Mar 13, 2020: Bausch Health to reduce debt by approximately $100 million using cash generated from operations
6.8 Mar 12, 2020: Alcon announces European launch of Vivity, the only presbyopia-correcting intraocular lens with X-WAVE technology
6.9 Mar 11, 2020: Alcon partners with Actress Cheryl Ladd to share her cataract journey, renewed vision and PanOptimist story
6.10 Mar 06, 2020: Pentax Medical donates USD430,000 worth of medical devices to fight novel corona virus (2019-ncov)
6.11 Feb 26, 2020: STAAR Surgical reports fourth quarter and full year 2019 results
6.12 Feb 26, 2020: NanoString Technologies releases fourth quarter and full year 2019 operating results and provides 2020 financial outlook
6.13 Feb 11, 2020: Abbott Laboratories: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officer
6.14 Feb 04, 2020: STAAR Surgical announces the EVO implantable lens US clinical trial is underway with 1st patient implanted at Price Vision Group in Indianapolis on january 30th
6.15 Feb 04, 2020: Santen and Verily establish joint venture to develop and commercialize unique Ophthalmic Devices
6.16 Jan 22, 2020: Abbott reports fourth-quarter 2019 results; announces strong forecast for 2020
6.17 Jan 13, 2020: STAAR Surgical gains supplemental lens approval for EVO Visian ICL to target post-cataract market opportunity
6.18 Jan 13, 2020: STAAR Surgical reports preliminary fourth quarter net sales growth of 25%
6.19 Jan 08, 2020: ABBOTT LABORATORIES: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers.
6.20 Dec 18, 2019: STAAR CFO to retire in 2020
6.21 Dec 17, 2019: STAAR Surgical announces strategic alliance agreement with California Center for Refractive Surgery (CCRS)
6.22 Dec 16, 2019: Bausch Health Resolves Stock Drop Litigation initially filed in October 2015
6.23 Dec 12, 2019: Bausch + Lomb expands intraocular lens portfolio
6.24 Dec 12, 2019: STAAR Surgical Company announces FDA IDE clinical study approval
6.25 Dec 03, 2019: Johnson & Johnson Vision introduces TECNIS Toric II 1-Piece IOL as new Monofocal Option for Cataract Patients with Astigmatism; Launching Multi-Center, Post-Market Clinical Trials Across U.S.

7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Intraocular Lens (IOL) - Pipeline Products by Stage of Development
Table 2: Intraocular Lens (IOL) - Pipeline Products by Segment
Table 3: Intraocular Lens (IOL) - Pipeline Products by Territory
Table 4: Intraocular Lens (IOL) - Pipeline Products by Regulatory Path
Table 5: Intraocular Lens (IOL) - Pipeline Products by Estimated Approval Date
Table 6: Intraocular Lens (IOL) - Ongoing Clinical Trials
Table 7: Intraocular Lens (IOL) Companies - Pipeline Products by Stage of Development
Table 8: Intraocular Lens (IOL) - Pipeline Products by Stage of Development
Table 9: Abbott Medical Optics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Intraocular Lens - Astigmatism - Product Status
Table 11: Intraocular Lens - Astigmatism - Product Description
Table 12: Intraocular Lens - Presbyopia - Product Status
Table 13: Intraocular Lens - Presbyopia - Product Description
Table 14: AcuFocus Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 15: IC-8 IOL - Product Status
Table 16: IC-8 IOL - Product Description
Table 17: AcuFocus Inc - Ongoing Clinical Trials Overview
Table 18: IC-8 IOL - A Prospective Study of Small Aperture Intraocular Lens (IOL) Implantation in KAMRA Inlay Patients After Inlay Removal
Table 19: IC-8 IOL - Clinical Evaluation of a Small Aperture Extended Depth of Focus Intraocular Lens
Table 20: IC-8 IOL - Interindividual Comparison Trial – Two Intraocular Lenses with Extended Depth of Focus
Table 21: Adaptilens LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 22: Adaptilens - Product Status
Table 23: Adaptilens - Product Description
Table 24: Adoptics AG (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 25: Shape-Changing Accommodating Intraocular Lens - Product Status
Table 26: Shape-Changing Accommodating Intraocular Lens - Product Description
Table 27: AkkoLens International BV Pipeline Products & Ongoing Clinical Trials Overview
Table 28: AkkoLens IOL - Product Status
Table 29: AkkoLens IOL - Product Description
Table 30: Alcon Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 31: AcrySof IQ ReSTOR 3.0D Toric IOL Diopter Range Expansion - Product Status
Table 32: AcrySof IQ ReSTOR 3.0D Toric IOL Diopter Range Expansion - Product Description
Table 33: AcrySof IQ ReSTOR Distant Dominant 2.5D - Product Status
Table 34: AcrySof IQ ReSTOR Distant Dominant 2.5D - Product Description
Table 35: AcrySof IQ ReSTOR Toric IOL Diopter Range Expansion - Product Status
Table 36: AcrySof IQ ReSTOR Toric IOL Diopter Range Expansion - Product Description
Table 37: AcrySof IQ Toric Diopter Range Expansion - Product Status
Table 38: AcrySof IQ Toric Diopter Range Expansion - Product Description
Table 39: AcrySof IQ Toric IOL Low Diopter Range Expansion - Product Status
Table 40: AcrySof IQ Toric IOL Low Diopter Range Expansion - Product Description
Table 41: AcrySof IQ Vivity Non-Diffractive IOL - Product Status
Table 42: AcrySof IQ Vivity Non-Diffractive IOL - Product Description
Table 43: FluidVision Lens - Product Status
Table 44: FluidVision Lens - Product Description
Table 45: Intrepid IOL - Product Status
Table 46: Intrepid IOL - Product Description
Table 47: Alcon Inc - Ongoing Clinical Trials Overview
Table 48: AcrySof IQ Vivity Non-Diffractive IOL - Evaluation of Quality of Vision and Visual Outcomes with Bilateral Implantation of the AcrySof Vivity Intraocular Lens with a Target of Slight Myopia in the Non-dominant Eye
Table 49: AcrySof IQ Vivity Non-Diffractive IOL - Single-center, Double-arm, Prospective Clinical Trial to Compare Visual Performance of Non-diffractive Extended Vision and Neutral Aspheric Monofocal Intraocular Lenses
Table 50: AcrySof IQ Vivity Non-Diffractive IOL - Vivity Insight: A Study of Patient Satisfaction and Visual Performance

List of Figures
Figure 1: Intraocular Lens (IOL) - Pipeline Products by Stage of Development
Figure 2: Intraocular Lens (IOL) - Pipeline Products by Segment
Figure 3: Intraocular Lens (IOL) - Pipeline Products by Territory
Figure 4: Intraocular Lens (IOL) - Pipeline Products by Regulatory Path
Figure 5: Intraocular Lens (IOL) - Pipeline Products by Estimated Approval Date
Figure 6: Intraocular Lens (IOL) - Ongoing Clinical Trials